This Article Full Text Full Text (PDF) All Versions of this Article: 38/6/1873    most recent STROKEAHA.106.474569v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Carter, A. M. Articles by Grant, P. J. Search for Related Content PubMed PubMed Citation Articles by Carter, A. M. Articles by Grant, P. J. Pubmed/NCBI databases Medline Plus Health Information Stroke Related Collections Acute Cerebral Infarction

(Stroke. 2007;38:1873.)
© 2007 American Heart Association, Inc.

Original Contributions

Predictive Variables for Mortality After Acute Ischemic Stroke

Angela M. Carter, PhD; Andrew J. Catto, PhD; Michael W. Mansfield, DM; John M. Bamford, MD Peter J. Grant, MD

From the Academic Unit of Molecular Vascular Medicine (A.M.C., A.J.C., M.W.M., P.J.G.), The LIGHT Laboratories, University of Leeds, Leeds, UK; and the Department of Neurology (J.M.B.), Leeds General Infirmary, Leeds, UK.

Correspondence to Professor Peter J. Grant, Academic Unit of Molecular Vascular Medicine, The LIGHT Laboratories, University of Leeds, Clarendon Way, Leeds, LS2 9JT, UK. E-mail P.J.Grant{at}leeds.ac.uk

Background and Purpose— Stroke is a major healthcare issue worldwide with an incidence comparable to coronary events, highlighting the importance of understanding risk factors for stroke and subsequent mortality.

Methods— In the present study, we determined long-term (all-cause) mortality in 545 patients with ischemic stroke compared with a cohort of 330 age-matched healthy control subjects followed up for a median of 7.4 years. We assessed the effect of selected demographic, clinical, biochemical, hematologic, and hemostatic factors on mortality in patients with ischemic stroke. Stroke subtype was classified according to the Oxfordshire Community Stroke Project criteria. Patients who died 30 days or less after the acute event (n=32) were excluded from analyses because this outcome is considered to be directly attributable to the acute event.

Results— Patients with ischemic stroke were at more than 3-fold increased risk of death compared with the age-matched control cohort. In multivariate analyses, age, stroke subtype, atrial fibrillation, and previous stroke/transient ischemic attack were predictive of mortality in patients with ischemic stroke. Albumin and creatinine and the hemostatic factors von Willebrand factor and β-thromboglobulin were also predictive of mortality in patients with ischemic stroke after accounting for demographic and clinical variables.

Conclusions— The results indicate that subjects with acute ischemic stroke are at increased risk of all-cause mortality. Advancing age, large-vessel stroke, atrial fibrillation, and previous stroke/transient ischemic attack predict mortality; and analysis of albumin, creatinine, von Willebrand factor, and β-thromboglobulin will aid in the identification of patients at increased risk of death after stroke.

Key Words: β-thromboglobulin • cerebral infarction • mortality • stroke • von Willebrand factor